Maya A. Dymova

Siberian Branch, Lavrentyev Avenue 8
Novosibirsk, NVS 630090, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Oncolytic Virus VV-GMCSF-Lact and Human GM-CSF Against GL261 Glioma in Immunocompetent Mice.

Oncolytic Virus VV-GMCSF-Lact and Human GM-CSF Against GL261 Glioma in Immunocompetent Mice.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 23, 2026

Drug-Induced Partial Immunosuppression for Preclinical Human Tumor Xenograft Models.

Drug-Induced Partial Immunosuppression for Preclinical Human Tumor Xenograft Models.

Journal: Cancers

Published: November 18, 2025

Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma.

Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma.

Journal: Cells

Published: August 11, 2025

Aptamers as a new frontier in targeted cancer therapy.

Aptamers as a new frontier in targeted cancer therapy.

Journal: Advanced drug delivery reviews

Published: July 29, 2025

Single-Cell Transcriptomic Changes in Patient-Derived Glioma and U87 Glioblastoma Cell Cultures Infected with the Oncolytic Virus VV-GMCSF-Lact.

Single-Cell Transcriptomic Changes in Patient-Derived Glioma and U87 Glioblastoma Cell Cultures Infected with the Oncolytic Virus VV-GMCSF-Lact.

Journal: International journal of molecular sciences

Published: June 23, 2025

RNA Interference of the Genes Associated with the Invasion of Brain Tumor Cells.

RNA Interference of the Genes Associated with the Invasion of Brain Tumor Cells.

Journal: Acta naturae

Published: March 17, 2025

Using Computer Modeling and Experimental Methods to Screen for Aptamers That Bind to the VV-GMCSF-LACT Virus.

Using Computer Modeling and Experimental Methods to Screen for Aptamers That Bind to the VV-GMCSF-LACT Virus.

Journal: Molecules (Basel, Switzerland)

Published: October 15, 2024

Analyzing aptamer structure and interactions: in silico modelling and instrumental methods.

Analyzing aptamer structure and interactions: in silico modelling and instrumental methods.

Journal: Biophysical reviews

Published: September 20, 2024

Characterizing Aptamer Interaction with the Oncolytic Virus VV-GMCSF-Lact.

Characterizing Aptamer Interaction with the Oncolytic Virus VV-GMCSF-Lact.

Journal: Molecules (Basel, Switzerland)

Published: December 19, 2023

Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact.

Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact.

Journal: Cells

Published: September 25, 2023

Design of the New Closo-Dodecarborate-Containing Gemcitabine Analogue for the Albumin-Based Theranostics Composition.

Design of the New Closo-Dodecarborate-Containing Gemcitabine Analogue for the Albumin-Based Theranostics Composition.

Journal: Molecules (Basel, Switzerland)

Published: February 10, 2023

Aptamers Enhance Oncolytic Viruses' Antitumor Efficacy.

Aptamers Enhance Oncolytic Viruses' Antitumor Efficacy.

Journal: Pharmaceutics

Published: November 25, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026